Esperion Therapeutics, Inc.
ESPR
$1.50
$0.000.00%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/5/2025
-
MarketBeat
3/5/2025
-
GuruFocus
3/5/2025
-
Stocktwits News Feed
3/5/2025
-
TipRanks Financial Blog
3/4/2025
-
Seeking Alpha: Transcripts
3/4/2025
-
SeekingAlpha
3/4/2025
-
MarketBeat
3/4/2025
-
MarketBeat
3/4/2025
-
GuruFocus
3/4/2025
-
SeekingAlpha
3/4/2025
-
Zacks Investment Research
3/4/2025
-
Globe Newswire
3/3/2025
-
Globe Newswire
3/3/2025
-
MarketBeat
2/28/2025
-
Insider Monkey
2/28/2025
-
MarketBeat
2/25/2025
-
Zacks Investment Research
2/22/2025
-
SeekingAlpha
2/19/2025
-
MarketBeat
2/18/2025
-
Globe Newswire
2/18/2025
-
Ticker Report
2/15/2025
-
GuruFocus
2/13/2025
-
Globe Newswire
2/11/2025
-
MarketBeat
2/11/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 7, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
734 887 3903
Address
3891 Ranchero Drive
Ann Arbor, MI 48108
Ann Arbor, MI 48108
Country
Year Founded
Business Description
Sector
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United...
more
